Sign up here to receive news updates via email.
-
September 23, 2025 |
Media, News and Updates, Press Releases
BPGbio Welcomes Back NAi Interrogative Biology® Platform Co-Inventor Slava Akmaev, Ph.D., as Chief Operating Officer and Chief AI Officer
read more -
September 4, 2025 |
Media, News and Updates, Press Releases
BPGbio Announces Completion of Enrollment for Phase 2b Trial of BPM31510 for Glioblastoma (GBM)
read more -
June 18, 2025 |
Media, News and Updates, Press Releases
BPGbio Announces Presentation of Preliminary Clinical Data Of Investigational BPM31510 For Primary CoQ10 Deficiency
read more -
May 16, 2025 |
Media, News and Updates, Press Releases
BPGbio General Counsel Ritesh Srivastava Named Shortlisted Nominee for 2025 LA Times Executive Leadership Awards
read more -
April 28, 2025 |
Media, News and Updates, Press Releases
BPGbio CEO Dr. Niven R. Narain Named to The Medicine Maker Power List 2025
read more -
April 25, 2025 |
Media, News and Updates, Press Releases
BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference
read more
